GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] proposal — a flair for special authorization posts — 34 comments in the full submission. View in context.
840
c/glp1canada·submitted 1 year ago by u/oskar_kaufmann

[Meta] proposal — a flair for special authorization posts

Formularybranch of 7 comments

proposal — a flair for special authorization posts. Nothing about this affects the ranking maths, before anyone asks. Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing. A rejected claim at the pharmacy…

Read the full submission and all 34 comments →

This branch

7 comments, started 1 year ago
u/careful_gradient3253 points·1 year ago

Spent three weeks on what turned out to be a quantity limit rather than a coverage question.

replysharereportpermalink
u/nikhil_asante25 points·1 year ago

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.

replysharereportpermalink
u/oskar_kaufmannOP35 points·1 year ago

a denial letter names a criterion, that is your handle

replysharereportpermalink
u/cagrilintide_enthusiast18 points·1 year ago

Correction: that is regulatory approval, not coverage. They are separate decisions by separate bodies.

replysharereportpermalink
u/incretin_ivypharmacology7 points·1 year ago

Correcting myself: it was a quantity limit rather than a denial, which changes the whole process.

replysharereportpermalink
u/oskar_kaufmannOP25 points·1 year ago

say the province or the answers will be wrong

replysharereportpermalink
u/teodor_jansen11 points·1 year ago

quantity limits are as common a barrier as coverage itself

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.